Company Filing History:
Years Active: 2003-2008
Title: The Innovations of Jeffrey Christiansen
Introduction
Jeffrey Christiansen is an accomplished inventor based in Yeronga, Australia. He has made significant contributions to the field of medical research, particularly in the area of cancer genetics. With a total of 2 patents, his work focuses on understanding and combating basal cell carcinoma.
Latest Patents
Christiansen's latest patents include groundbreaking inventions related to tumor suppressor genes. The first patent addresses the basal cell carcinoma tumor suppressor protein, which provides insights into the inactivation of a tumor suppressor gene that is a causal factor in nevoid basal cell carcinoma syndrome and various sporadic basal cell carcinomas. This invention highlights the NBCCS gene as a homologue of the patched (ptc) gene. The second patent also pertains to the basal cell carcinoma tumor suppressor gene, reiterating the importance of this gene's inactivation in the context of cancer research.
Career Highlights
Jeffrey Christiansen is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to collaborate with leading experts in the field and contribute to vital research initiatives.
Collaborations
Some of his notable coworkers include Michael C. Dean and Heidi Eve Hahn, who share a commitment to advancing medical science and improving patient outcomes.
Conclusion
Jeffrey Christiansen's innovative work in cancer genetics exemplifies the impact of research on public health. His patents and collaborations continue to pave the way for advancements in understanding and treating basal cell carcinoma.